SCHEMBL6998914

SCHEMBL6998914

CCOC(=O)C1=CN(C)N(OCC)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.38
TSHR P16473 2/20 0.37
MAPT P10636 4/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ACHE P22303 1/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35
CA12 O43570 4/20 0.35
CA1 P00915 4/20 0.35
CA2 P00918 4/20 0.35
CA7 P43166 4/20 0.35
CA9 Q16790 4/20 0.35
CA14 Q9ULX7 4/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7002090 0.80 CYP1A2 (0.40) HSP90AA1TSHRMAPTKDM4EACHE
SCHEMBL6998918 0.77 HSP90AA1 (0.38) HSP90AA1TSHRMAPTSMN1; SMN2KDM4E
SCHEMBL7002092 0.73 TSHR (0.39) HSP90AA1TSHRMAPTKDM4EACHE
SCHEMBL31309801 0.71 ACHE (0.41) HSP90AA1TSHRKDM4EACHEKMT2A
SCHEMBL14195937 0.68 CYP1A2 (0.48) TSHR
SCHEMBL23382300 0.67 KMT2A (0.40) TSHRMAPTKDM4EACHEKMT2A
SCHEMBL14593070 0.67 KDM4E (0.40) TSHRMAPTSMN1; SMN2KDM4EKMT2A
SCHEMBL14067651 0.66 TSHR (0.42) HSP90AA1TSHRKDM4EACHEKMT2A
SCHEMBL9233379 0.66 ALDH1A1 (0.42) HSP90AA1TSHRMAPTKDM4EACHE
SCHEMBL2585836 0.66 TSHR (0.38) TSHRMAPTKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1123296-B1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION PFIZER LTD (GB) 2003-09-17 EP disclosed
US-6333330-B1 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction PFIZER INC. 2001-12-25 US disclosed